Insilico Medicine IP Limited

Chine


Commandez votre montre hebdomadaire Insilico Medicine IP Limited
Quantité totale PI 135
Rang # Quantité totale PI 9 839
Note d'activité PI 3,1/5.0    205
Rang # Activité PI 3 294
Classe Nice dominante Appareils et instruments scienti...

Brevets

Marques

0 9
14 0
112 0
0
 
Dernier brevet 2025 - Werner syndrome recq helicase (w...
Premier brevet 2020 - Tlr inhibitors
Dernière marque 2025 - INSILICO PHARMACEUTICAL SUPERINT...
Première marque 2023 - LLOLM

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Computers; Computer software applications, downloadable, for using artificial intelligence for au...
Invention Werner syndrome recq helicase (wrn) inhibitors and methods of uses thereof. Provided compounds, c...
Invention Novel compounds as cyclic gmp-amp synthase inhibitor and uses thereof. Described herein are cycli...
Invention Scalable framework for 3d molecular design via language modeling and reinforcement learning. A co...
Invention Crystalline tead inhibitor and uses thereof. Described herein are crystalline forms of a small mo...
Invention Tead inhibitors and methods of uses thereof. The disclosure provides for compounds and methods fo...
Invention Tead inhibitor combinations and uses thereof. Described herein are methods of treating cancer usi...
Invention Crystalline cyclin-dependent kinase (cdk) 12 and/or cdk13 inhibitor and uses thereof. Described h...
Invention Cyclin-dependent kinase (cdk) 12 and/or cdk13 inhibitor combinations and uses thereof. Described ...
Invention Novel compounds as glucocorticoid receptor modulators and uses thereof. Described herein are gluc...
2024 Invention Novel compounds as glp-1r agonists and uses thereof. Described herein are GLP-1R agonists and pha...
Invention Methods and systems for alchemical binding free energy. A computer-implemented method can include...
Invention Novel compounds as modulators of sodium channels and uses thereof. Described herein are sodium ch...
Invention Cbl-b inhibitors and methods of uses thereof. Described herein are Casitas B-lineage lymphoma (Cb...
Invention 3cl-protease inhibitors for treating or preventing veterinary coronavirus infections. Provided he...
Invention Novel compounds as pkmyt1 inhibitors and use thereof. Disclosed are compounds or pharmaceutically...
Invention Combinations treatments of diacylglycerol kinase (dgk) alpha inhibitors and other therapies. Desc...
Invention Bifunctional compounds for targeting pkmyt1 and methods of use. Disclosed herein are bifunctional...
Invention Fused ring compound, and preparation method therefor and use thereof. A fused ring compound, and ...
Invention Method and medicament for treating endometriosis. Provided is a method and a medicament for treat...
Invention Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp1) inhibitors and uses thereof. Described...
Invention Crytsalline forms of ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp1) inhibitors and us...
Invention Crystalline beta-lactam derivatives and uses thereof. Described herein are crystalline forms of a...
P/S Downloadable and recorded computer software platforms using artificial intelligence for automated...
Invention Pharmaceutical formulations for inhalation and uses thereof. Provided herein are pharmaceutical f...
Invention Ectonucleotide pyrophosphatase/phosphodiesterase 1 (enpp1) inhibitor combinations and uses thereo...
Invention Crystalline tnik inhibitor and uses thereof. Described herein are crystalline forms of a TNIK inh...
Invention Substituted thiazole compounds as cdk2/4/6 inhibitors and methods of use thereof. The disclosure ...
Invention Synthesis of macrocyclic compound and medical use of macrocyclic compound. Provided in the presen...
Invention Kras inhibitors and uses thereof. KRAS mutation inhibitors and pharmaceutical compositions compri...
Invention Prmt5 inhibitors and uses thereof. Provides for compounds and compositions for modulating or inhi...
Invention Nlrp3 inflammasome inhibitors and uses thereof. Described herein are NOD-like receptor protein 3 ...
Invention Spiro derivatives as wrn inhibitors. Provided compounds of Formula (I) or pharmaceutically accept...
Invention Small molecule inhibitors of ubiquitin specific protease 1 (usp1) and uses thereof. The disclosur...
Invention Prolyl hydroxylase domain-containing protein (phd) inhibitors, combinations and uses thereof. Des...
Invention Crystalline prolyl hydroxylase domain-containing protein (phd) inhibitor and uses thereof. Crysta...
Invention Crystalline prolyl hydroxylase domain-containing protein (phd) inhibitor and uses thereof. Descri...
Invention Crystalline sars-cov-2 inhibitor and uses thereof. Described herein are crystalline forms of a sm...
Invention Crystalline lysine acetyltransferase 6a (kat6a) inhibitor and uses thereof. Described herein are ...
Invention Lysine acetyltransferase 6a (kat6a) inhibitor, combinations and uses thereof. Described herein ar...
Invention Crystalline methionine adenosyltransferase 2a (mat2a) inhibitor and uses thereof. Described herei...
Invention Methionine adenosyltransferase 2a (mat2a) inhibitor combinations and uses thereof. Described here...
Invention Nlrp3 inflammasome inhibitors and uses thereof. Described herein are NLRP3 inflammasome inhibitor...
Invention Inhibitors of fgfr2 and fgfr3 and uses thereof. Described herein are FGFR2 and FGFR3 inhibitors a...
Invention Cdk8/19 dual inhibitors and methods of use thereof. The disclosure provides for compounds and met...
Invention Pro inhibitors for treating coronavirus infections. Provided herein are compounds, pharmaceutical...
P/S Downloadable and recorded computer software; recorded or downloadable computer software platforms...
P/S Downloadable computer software applications for estimating the relative binding free energy to pr...
Invention Inhibitors of kif18a and uses thereof. Described herein are KIF18A inhibitors and pharmaceutical ...
2023 Invention Protein tyrosine phosphatase inhibitors and uses thereof. Provided are compounds, methods for mod...